Provided by Tiger Fintech (Singapore) Pte. Ltd.

ICP Ltd

0.008
+0.000
Volume:41.00K
Turnover:328.00
Market Cap:26.74M
PE:-22.54
High:0.008
Open:0.008
Low:0.008
Close:0.008
Loading ...

Singapore Shares Rise Despite Trump's Trade Policies; ICP Surges 14%; Yangzijiang Shipbuilding Jumps 9%

MT Newswires
·
Yesterday

ICP Faces Delisting as Controlling Shareholder Launches Exit Offer; Shares Surge 14%

MT Newswires
·
Yesterday

ICP Limited’s Controlling Shareholder Seeks to Delist Company; Makes Offer of 0.9 Cents Per Share

The Edge Singapore
·
Yesterday

SG Morning Call| STI Opened Higher; ICP Surged 14% On Controlling Shareholder Seeks To Delist Company

TigerNews SG
·
Yesterday

SG Morning Call | Singapore Citizens Can Apply for S$6,000 Unemployment Benefit Scheme from Apr 15

TigerNews SG
·
15 Apr

Binance will adjust the collateralization ratio for certain assets in the Unified Account section

Blockbeats
·
08 Apr

Press Release: InnoCare Releases 2024 Results and Business Highlights

Dow Jones
·
27 Mar

California Judge Dismisses Class Action Lawsuit Against Dfinity Foundation

Blockbeats
·
27 Mar

AI Agent Public Chain Hibit Completes $5 Million Funding Round, with Investment from Waterdrop Capital and Others

Blockbeats
·
24 Mar

InnoCare Pharma's ICP-248 Combo Therapy Approved for Phase III Trial

MT Newswires Live
·
19 Feb

Singapore Shares Overcome Trade War Worries. STI up 0.36%; F&N up 3%; DBS up 1.6%; UOB up 1%; ST Engineering Down 2%

MT Newswires
·
10 Feb

ICP's Profit Surges 93% in Fiscal H1; Shares Zoom 14%

MT Newswires
·
10 Feb

InnoCare Pharma Unit Outsources Manufacturing, Commercialization License for Tumor Drug

MT Newswires Live
·
21 Jan

ICP to Acquire Minority Stake in Japan-based Hotel Property

MT Newswires
·
17 Jan

ICP Completes Acquisition of Property in Seol, South Korea

MT Newswires
·
09 Dec 2024

ICP Acquires Seoul Property for 120 Billion Won

MT Newswires
·
14 Nov 2024

BRIEF-ICP Says Acquisition Of Property In South Korea

Reuters
·
13 Nov 2024

ICP Grants 27.1 Million Shares Under Performance Share Plan

MT Newswires
·
11 Nov 2024

InnoCare Pharma (SEHK:9969) Achieves Key Milestone with ICP-488 Phase II Success in Psoriasis Treatment

Simply Wall St.
·
03 Nov 2024